Merit Financial Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.6M Sell
84,634
-233,479
-73% -$11.4M 0.03% 460
2026
Q1
$13.6M Buy
318,113
+231,157
+266% +$9.94M 0.1% 183
2025
Q4
$3.81M Buy
86,956
+17,615
+25% +$729K 0.03% 429
2025
Q3
$2.86M Buy
69,341
+28,581
+70% +$1.15M 0.03% 455
2025
Q2
$1.8M Buy
40,760
+7,307
+22% +$292K 0.02% 565
2025
Q1
$1.24M Buy
33,453
+20,325
+155% +$724K 0.02% 579
2024
Q4
$437K Buy
+13,128
New +$426K 0.01% 768

Other funds holding EXEL

Merit Financial Group's EXEL Position: Q2 2026 in Review

Merit Financial Group reduced its Exelixis (EXEL) stake by 73% in Q2 2026, selling an estimated $11.4M and leaving 84,634 shares worth $4.6M. The position accounts for 0.03% of the portfolio, ranked #460.

Merit Financial Group first reported a position in EXEL in Q4 2024 and has held it in 7 quarters since. The position peaked at $13.6M in Q1 2026. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Merit Financial Group held 84,634 shares of Exelixis worth $4.6M as of Q2 2026.
  • Merit Financial Group sold 233,479 Exelixis shares in Q2 2026, an estimated $11.4M.
  • Exelixis made up 0.03% of Merit Financial Group's portfolio in Q2 2026, its #460 holding.
  • Merit Financial Group first reported a position in Exelixis in Q4 2024 and has held it in 7 quarters since.
  • Merit Financial Group's Exelixis position peaked at $13.6M in Q1 2026.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Merit Financial Group's 13F filing for Q2 2026, filed 17 Jul 2026.